Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)

1990-472X

Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации

10190

10.18499/1990-472X-2024-25-4-73-78

Pathopfysiology of arterial hypertension in chronic kidney disease

Nekrasova

Светлана Vladimirovna

studentvetanekras@yandex.ruMakeeva

Анна

к.б.н., доцент кафедры патологической физиологииmakeeva81@mail.ruBolotskikh

Vladimir Ivanovich

MD, Professor, Head of the Department of Pathological Physiologypatfiz@vrngmu.ruBerezhnova

Tatyana Alexandrovna

Doctor of Medicine, Professor, Head of the Department of Pharmacologyberezhnova-tatjana@rambler.ruNekrasova

Natalya Vasilevna

PhD, Associate Professor of the Department of Hospital Therapy and Endocrinologygospterap@vrngmu.ruBabenko

Nina Ivanovna

PhD, Assistant of the Department of Hospital Therapy and Endocrinologynibabenko@mail.ru

Burdenko VSMU of the Ministry of Health of the Russian Federation

27122024

2547378

09012025

2025

Due to the fact that in modern clinical practice, doctors are increasingly faced with kidney disease of different origins, due to a set of concomitant pathologies such as arterial hypertension, diabetes mellitus, metabolic syndrome. In this regard, the influence of hypertension on the development of chronic kidney disease is of particular relevance. To date, it has been proven that: genetic factors, the presence and degree of albuminuria, high cholesterol, abdominal obesity, diabetes, the use of non-steroidal anti-inflammatory drugs, socio-economic factors, racial and ethnic differences, lifestyle are factors affecting the control and severity of hypertension. At the moment, this pathology is a global problem that affects the quality of life of people and mortality from the corresponding complications. When analyzing the statistical data of the Health Ministry of the Russian Federation, as well as other developed countries, we see an increase in morbidity and mortality from chronic kidney disease, especially in people over 60. According to forecasts, by 2025, the number of patients with arterial hypertension will increase to 1.5 billion people. In this regard, it is of interest to study the clinical case in order to extrapolate the idea of the interconnected pathogenetic effect of pathological phenomena on the patient's health.

chronic kidney diseasecardiovascular diseaseshypertensionblood pressurealbuminuria.

хроническая болезнь почексердечно-сосудистые заболеванияартериальная гипертензияартериальное давлениеальбуминурия.

1. Статистический сборник Министерства здравоохранения Российской Федерации «Общая заболеваемость взрослого населения России в 2019 году». М. 2020. 137 с.

2. Статистический сборник Министерства здравоохранения Российской Федерации «Общая заболеваемость населения старше трудоспособного возраста России в 2012 году». М. 2013. 182 с.

3. U S Renal Data System, USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, Md, USA, 2010

4. Maranduca MA, Clim A, Pinzariu AC, Statescu C, Sascau RA, Tanase DM, Serban DN, Branisteanu DC, Branisteanu DE, Huzum B, Serban IL. Role of arterial hypertension and angiotensin II in chronic kidney disease (Review). Exp Ther Med. 2023 Feb 16;25(4): Р.153.DOI: 10.3892/etm.2023.11852.

5. Qian Q. Salt. Water and Nephron: Mechanisms of Action and Link to Hypertension and Chronic Kidney Disease.Nephrology (Carlton). 2018

10.

11.

6. Judd E, Calhoun DA. Management of hypertension in CKD: beyond the guidelines. Adv Chronic Kidney Dis. 2015 Mar;22(2). Р.116-22. doi: 10.1053/j.ackd.2014.12.001.

12.

13.

7. Ku E, Lee BJ, Wei J, Weir MR. Hypertension in CKD: Core Curriculum 2019. Am J Kidney Dis. 2019 Jul;74(1):120-131. D: 10.1053/j.ajkd.2018.12.044. Epub 2019 Mar 19. PMID: 30898362.

14.

15.

8. De Bhailis ÁM, Kalra PA. Hypertension and the kidneys. Br J Hosp Med (Lond). 2022 May 2;83(5):1-11. DOI: 10.12968/hmed.2021.0440. Epub 2022 May 27. PMID: 35653320.

16.

17.

9. Georgianos PI, Agarwal R. Hypertension in chronic kidney disease-treatment standard 2023. Nephrol Dial Transplant. 2023 Nov 30;38(12):2694-2703. DOI: 10.1093/ndt/gfad118.